20 likes | 196 Views
High Dose Ascorbic Acid to Treat CMT1A. MDA &CMTA are sponsors Futility Design WSU, Hopkins, U Rochester are sites CMTNS is primary outcome measure Skin biopsy as a secondary measure. CMT1A Trial. 90 patients enrolled Goal is 100 patients in trial 8 drop outs
E N D
High Dose Ascorbic Acid to Treat CMT1A • MDA &CMTA are sponsors • Futility Design • WSU, Hopkins, U Rochester are sites • CMTNS is primary outcome measure • Skin biopsy as a secondary measure
CMT1A Trial • 90 patients enrolled • Goal is 100 patients in trial • 8 drop outs • Goal is to close enrollment by years end • Starting to see patients for 18 month visit • GI side effects have not proved limiting